⌘K

Login Start Free

Home/Filings/4/0001209191-03-031725

4//SEC Filing

APRILE PETER C 4

Accession 0001209191-03-031725

CIK 0000737207other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 5:08 PM ET

Size

9.9 KB

Accession

0001209191-03-031725

Insider Transaction Report

Form 4

Period: 2003-11-20

NASTECH PHARMACEUTICAL CO INCNSTK

Other

Transactions

Sale
Nastech Pharmaceutical Co.Common Stock
2003-11-20$9.50/sh−2,000$19,000→ 725 total
Sale
Nastech Pharmaceutical Co.Common Stock
2003-11-20$9.52/sh−725$6,902→ 0 total
Exercise of In-Money
Nastech Pharmaceutical Stock Options
2003-11-20$7.50/sh−203$1,523→ 37,333 total
Exercise: $7.50From: 2003-01-04Exp: 2006-01-04→ CommonStock Options (203 underlying)
Exercise of In-Money
Nastech Pharmaceutical Stock Options
2003-11-20$8.59/sh−2,522$21,664→ 34,811 total
Exercise: $8.59From: 2002-08-31Exp: 2006-08-31→ CommonStock Options (2,522 underlying)
Purchase
Nastech Pharmaceutical Co. Common Stock
2003-11-20$7.50/sh+203$1,523→ 203 total
Purchase
Nastech Pharmaceutical Co.Common Stock
2003-11-20$8.59/sh+2,522$21,664→ 2,725 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NASTECH PHARMACEUTICAL CO INC

CIK 0000737207

Entity typeother

Related Parties

1

filerCIK 0001249344

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 5:08 PM ET
Size: 9.9 KB

View on SEC.gov